Schedule 13G ownership disclosure

Phathom Pharmaceuticals Inc

Security class unavailable · CUSIP: 71722W107

Event date: 2022-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-23-020303
Form type
SC 13G/A
Filer
Medicxi Growth I LP
CIK
CIK 1690310
Filed
Jan 31, 2023
Reporting period
Dec 31, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub